Interestingly, OS was poorest in breast cancer patients with both low LOXL4 levels and high collagen I or IV expression (Figure 6B–6C, P = 0.037, HR = 0.6718 and P = 0.037, HR = 0.6619, respectively). This evidence concerns the gene LOXL4 and breast cancer.